Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.25.1 (
proteasome
)
28,817
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Skeletal muscle has high energy requirement and alterations in metabolism are associated with pathological conditions causing muscle wasting and impaired regeneration. Congenital muscular dystrophy type 1A (MDC1A) is a severe muscle disorder caused by mutations in the LAMA2 gene.
Leigh syndrome
(LS) is a neurometabolic disease caused by mutations in genes related to mitochondrial function. Skeletal muscle is severely affected in both diseases and a common feature is muscle weakness that leads to hypotonia and respiratory problems. Here, we have investigated the bioenergetic profile in myogenic cells from MDC1A and LS patients. We found dysregulated expression of genes related to energy production, apoptosis and
proteasome
in myoblasts and myotubes. Moreover, impaired mitochondrial function and a compensatory upregulation of glycolysis were observed when monitored in real-time. Also, alterations in cell cycle populations in myoblasts and enhanced caspase-3 activity in myotubes were observed. Thus, we have for the first time demonstrated an impairment of the bioenergetic status in human MDC1A and LS muscle cells, which could contribute to cell cycle disturbance and increased apoptosis. Our findings suggest that skeletal muscle metabolism might be a promising pharmacological target in order to improve muscle function, energy efficiency and tissue maintenance of MDC1A and LS patients.
...
PMID:Bioenergetic Impairment in Congenital Muscular Dystrophy Type 1A and Leigh Syndrome Muscle Cells. 2836 54
Analysis of gene expression data by clustering and visualizing played a central role in obtaining biological knowledge. Here, we used Pearson's correlation coefficient of multiple-cumulative probabilities (PCC-MCP) of genes to define the similarity of gene expression behaviors. To answer the challenge of the high-dimensional MCPs, we used icc-cluster, a clustering algorithm that obtained solutions by iterating clustering centers, with PCC-
MCP
to group genes. We then used
t
-statistic stochastic neighbor embedding (t-SNE) of KC-data to generate optimal maps for clusters of
MCP
(t-SNE-MCP-O maps). From the analysis of several transcriptome data sets, we demonstrated clear advantages for using icc-cluster with PCC-
MCP
over commonly used clustering methods. t-
SNE
-
MCP
-O was also shown to give clearly projecting boundaries for clusters of PCC-
MCP
, which made the relationships between clusters easy to visualize and understand.
...
PMID:Multiple-cumulative probabilities used to cluster and visualize transcriptomes. 2922 87